D. E. Shaw & Co., Inc. Pulmonx Corp Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 489,880 shares of LUNG stock, worth $818,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,880

Previous 486,555 0.68%

Holding current value

$818,099

Previous $3.27 Million 61.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.57 - $6.87 $8,545 - $22,842	3,325 Added 0.68%	489,880 $1.27 Million
Q1 2025 May 15, 2025	BUY	$5.68 - $9.22 $532,323 - $864,089	93,719 Added 23.86%	486,555 $3.27 Million
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.71 $190,050 - $247,097	32,049 Added 8.88%	392,836 $2.67 Million
Q3 2024 Nov 14, 2024	SELL	$5.59 - $8.58 $101,911 - $156,421	-18,231 Reduced 4.81%	360,787 $2.99 Million
Q2 2024 Aug 14, 2024	SELL	$5.77 - $9.82 $301,649 - $513,379	-52,279 Reduced 12.12%	379,018 $2.4 Million
Q1 2024 May 15, 2024	SELL	$8.71 - $14.65 $1.67 Million - $2.8 Million	-191,291 Reduced 30.73%	431,297 $4 Million
Q4 2023 Feb 14, 2024	SELL	$7.89 - $13.14 $361,125 - $601,417	-45,770 Reduced 6.85%	622,588 $7.94 Million
Q3 2023 Nov 14, 2023	SELL	$9.88 - $14.0 $474,437 - $672,280	-48,020 Reduced 6.7%	668,358 $6.9 Million
Q2 2023 Aug 14, 2023	BUY	$10.78 - $13.65 $1.53 Million - $1.94 Million	142,214 Added 24.77%	716,378 $9.39 Million
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $2.4 Million - $4.01 Million	320,174 Added 126.06%	574,164 $6.42 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $1.25 Million - $4.41 Million	253,990 New	253,990 $2.14 Million
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $888,949 - $1.13 Million	-23,636 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $1.04 Million - $1.6 Million	23,636 New	23,636 $1.08 Million

Others Institutions Holding LUNG

# of Institutions

116

Shares Held

33.9M

Call Options Held

Put Options Held

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $62.2M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account